FGF23 and Cognitive impairment: Therefore, a longer follow-up study on the prognosis of MHD patients participating in this experiment is needed to further explore the effects of age, dialysis age, BMI, blood calcium, and the level of FGF-23 on cognitive impairment in MHD patients.